WAVEMAN · COMPANY

DD · Dupont De Nemours, Inc.

LIVE

TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475

← ALL COMPANIES

DD

Name: DuPont de Nemours, Inc. (DD) insider trading and ownership data
Creator: WaveMan
License: https://wave-man.com/terms

DuPont de Nemours, Inc.

PHARMA & BIOTECH · PLASTIC MATERIALS, SYNTH RESINS & NONVULCAN ELASTOMERS · CIK 0001666700

CONGRESS · 1☆ WATCH

INSIDER NET · 180D

-$12.7K

open-market buys minus sells, Form 4 codes P and S

INSIDER BUYERS · 180D

CONGRESS BUYERS · 1Y

FUNDS ADDED · QTR

128

13F, latest reported quarter

REVENUE GROWTH

+1.9%

XBRL, annual

NET MARGIN

-11.4%

SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST

INSIDERS

net -$12.7K over 180 days

more than 62% of Pharma & Biotech

CONGRESS

1 member bought in the last year

the lowest in Pharma & Biotech

FUNDS

128 funds added or opened last quarter

more than 74% of Pharma & Biotech

REVENUE

+1.9% year over year

below 51% of Pharma & Biotech

MARGIN

-11.4% net margin

more than 54% of Pharma & Biotech

BUYBACKS

no share repurchases reported

SHORT

3.9% of shares outstanding short · 2.9 days to cover · settled 2026-07-31

below 53% of Pharma & Biotech

THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET

128 funds added or opened positions in the latest 13F quarter, of 1,126 holders.

1 member of Congress reported buying it this year.

The year, with the filings on it

Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail

TOTAL 12M RETURN +39.6%

+39.6%12M

INSIDER SELL

INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY

Live price

Daily candles from TradingView, on their licence — no filings are marked on this one

WHY THIS NAME IS ON THE DESK

The complete filing record, in one place.

The record shows a net $12.7K sold by insiders over 180 days, 128 funds added last quarter, 1 Congress member(s) bought in 12 months. Every figure is a federal filing, dated the day it became public.

Backtest this pattern Open the screener

Same sector, ranked by filing activity

Sector from the SEC's own SIC classification

UTHR CPIX MRNA REGN LLY ALNY ELF CITR MDGL DNA VRTX NUVL

Insider transactions

Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, DuPont de Nemours, Inc. insiders sold a net $12.7K of stock across 28 Form 4 purchases and sales, with 0 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-05.

INSIDER

FILED

VALUE

Koch Lori

CEO

SELL

2026-06-02

260.98

$12.7K

Hoover Erik T.

SVP & General Counsel

SELL

2025-11-28

6,005.0

$238.9K

Koch Lori

CEO

SELL

2025-11-28

9,011.0

$355.6K

Larrabee Steven P.

SVP & CIO

SELL

2025-09-15

4,000.0

$307.9K

Larrabee Steven P.

SVP & CIO

SELL

2025-09-15

39,208.0

$3.0M

28 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 23 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders

13F · holdings as of the latest quarter funds have reported

BlackRock, Inc.

10,637,868.0 sh

$1.4B

VANGUARD CAPITAL MANAGEMENT LLC

8,935,728.0 sh

$1.2B

VANGUARD PORTFOLIO MANAGEMENT LLC

6,405,233.0 sh

$868.8M

Invesco Ltd.

3,792,235.0 sh

$514.4M

GEODE CAPITAL MANAGEMENT, LLC

3,747,286.0 sh

$506.3M

SCHEDULE 13D/G

No 5%+ ownership filings

Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.

FORM 144

No planned-sale notices

No insider has notified an intent to sell. This is the panel to watch after a run-up.

Fund concentration

N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show

Invesco S&P 500 Equal Weight Materials ETF

$6.7M POSITION · AS OF 2026-04-30

3.7%

Adaptiv Select ETF

$6.1M POSITION · AS OF 2026-04-30

3.6%

Nomura Value Fund

$69.4M POSITION · AS OF 2026-02-27

3.5%

Nomura VIP Value Series

$4.6M POSITION · AS OF 2026-03-31

3.0%

Invesco Dorsey Wright Basic Materials Momentum ETF

$3.0M POSITION · AS OF 2026-04-30

2.9%

Monarch Volume Factor Dividend Tree Index ETF

$2.8M POSITION · AS OF 2026-02-28

2.9%

SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK

Corporate PAC

FEC · the company-connected political action committee's own receipts and spending — committee totals only, never individual donors

Employees Of Dupont Pac - Dupont De Nemours, Inc.

CYCLE 2026 · $24K SPENT

$33.5K

FEDERAL ELECTION COMMISSION · MATCHED BY THE PAC'S CONNECTED ORGANISATION

Fundamentals

Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all

	2025-12	2024-12	2023-12	2022-12
REVENUE	$6.8B	$6.7B	$6.6B	$13.0B
NET INCOME	$88.0M	$703.0M	$423.0M	$5.9B
EPS (DILUTED)	-1.86	1.68	0.94	11.75
OPERATING CASH FLOW	—	—	—	$588.0M
CASH	$715.0M	$1.8B	$2.4B	$3.7B
LONG-TERM DEBT	—	—	$7.9B	$8.1B
DIVIDENDS PAID	$597.0M	$635.0M	$651.0M	$652.0M

SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-05 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE